149 related articles for article (PubMed ID: 38349474)
21. Tumor-associated macrophages in direct contact with prostate cancer cells promote malignant proliferation and metastasis through NOTCH1 pathway.
Shi F; Sun MH; Zhou Z; Wu L; Zhu Z; Xia SJ; Han BM; Zhao YY; Jing YF; Cui D
Int J Biol Sci; 2022; 18(16):5994-6007. PubMed ID: 36439868
[No Abstract] [Full Text] [Related]
22. Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer.
Xie X; Dou CX; Luo MR; Zhang K; Liu Y; Zhou JW; Huang ZP; Xue KY; Liang HY; Ouyang AR; Ma SX; Yang JK; Zhou QZ; Guo WB; Liu CD; Zhao SC; Chen MK
Front Immunol; 2022; 13():946209. PubMed ID: 36569837
[TBL] [Abstract][Full Text] [Related]
23. Single-cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers.
Wei J; Yu W; Chen J; Huang G; Zhang L; Chen Z; Hu M; Gong X; Du H
Mol Oncol; 2023 Apr; 17(4):611-628. PubMed ID: 36587392
[TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate - An institutional study.
Hadimani SM; Das S; Harish KG
J Cancer Res Ther; 2023 Apr; 19(Supplement):S300-S305. PubMed ID: 37148007
[TBL] [Abstract][Full Text] [Related]
25. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
Front Immunol; 2022; 13():777724. PubMed ID: 35154101
[TBL] [Abstract][Full Text] [Related]
27. BACH1 as a potential target for immunotherapy in glioblastomas.
Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C
Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy.
Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z
Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages.
Xu L; Chen Y; Liu L; Hu X; He C; Zhou Y; Ding X; Luo M; Yan J; Liu Q; Li H; Lai D; Zou Z
PLoS Genet; 2024 Apr; 20(4):e1011235. PubMed ID: 38648200
[TBL] [Abstract][Full Text] [Related]
30. Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis.
Chen C; Wang S; Wang N; Zheng Y; Zhou J; Hong M; Chen Z; Wang S; Wang Z; Xiang S
Phytomedicine; 2023 Nov; 120():155076. PubMed ID: 37716031
[TBL] [Abstract][Full Text] [Related]
31. Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing.
Lyu F; Gao X; Ma M; Xie M; Shang S; Ren X; Liu M; Chen J
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370891
[TBL] [Abstract][Full Text] [Related]
32. Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer.
Xie T; Fu DJ; Li KJ; Guo JD; Xiao ZM; Li Z; Zhao SC
Aging (Albany NY); 2024 Jan; 16(2):1581-1604. PubMed ID: 38240702
[TBL] [Abstract][Full Text] [Related]
33. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
34. Establishment of an age- and tumor microenvironment-related gene signature for survival prediction in prostate cancer.
Chen L; Zhang M; Zhou J; Zhang L; Liang C
Cancer Med; 2022 Nov; 11(22):4374-4388. PubMed ID: 35535438
[TBL] [Abstract][Full Text] [Related]
35. Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment.
Galván GC; Johnson CB; Price RS; Liss MA; Jolly CA; deGraffenried LA
Nutr Cancer; 2017 Oct; 69(7):996-1002. PubMed ID: 28945110
[TBL] [Abstract][Full Text] [Related]
36. Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma.
Zheng X; Weigert A; Reu S; Guenther S; Mansouri S; Bassaly B; Gattenlöhner S; Grimminger F; Pullamsetti S; Seeger W; Winter H; Savai R
Cancer Res; 2020 Oct; 80(20):4414-4425. PubMed ID: 32699134
[TBL] [Abstract][Full Text] [Related]
37. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
38. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
[TBL] [Abstract][Full Text] [Related]
39. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
[TBL] [Abstract][Full Text] [Related]
40. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
